In March 2021, the American Cancer Society (ACS) created the ACS National Consortium to establish a collective national response to the detrimental impact of the COVID-19 pandemic on cancer screening and care. The consortium members included 28 government agencies, health organizations, national roundtables and cancer advocacy organizations, professional societies and associations, research institutions, and other relevant industry partners. The consortium members met to identify, discuss, and agree on consensus recommendations for improving cancer screening and care in the United States.
CDC Priorities
Responding to the COVID-19 Pandemic: Improving Cancer Screening and Care in the United States
